CompletedPhase 1

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria

Nigeria90 participantsStarted 2009-08

Plain-language summary

Women diagnosed with incomplete abortion in this health facility will be randomized to receive one of the following regimens: 400 mcg sublingual misoprostol in one dose or standard surgical treatment (MVA). The investigators hypothesize that treatment of incomplete abortion with misoprostol using 400 mcg administered sublingually will be as effective as surgical evacuation.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * no contraindications to misoprostol * uterine size was not larger than 12 weeks * there were no signs of severe infection * haemodynamically stable * in general good health * willing to provide contact information Exclusion Criteria: * an IUD in place * ectopic pregnancy * aged below 18 years and had no accompanying adult to provide informed consent

What they're measuring

Complete abortion without recourse to surgical intervention

Timeframe: follow up visit 7 days after initial treatment

Trial details

NCT IDNCT01539408

SponsorGynuity Health Projects

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-10

View on ClinicalTrials.gov More Incomplete Abortion trials